Barely Significant
← all excerpts

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy.

Clin Transl Med · 2020 · PMC7752154 · PMID 33377654

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

marginally significantP = 0.07so close (0.05 < p ≤ 0.1)
In addition, the identified immunomodulatory signature was significantly associated with improved overall survival in urothelial carcinoma clinical trial (log‐rank test, P = 0.004; Figure 3A ) and marginally significant in melanoma trial (log‐rank test, P = 0.07; Figure 3B ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.